NEW YORK, May 6, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Waters Corp. (NYSE: WAT), Allegion plc (NYSE: ALLE), Curtiss-Wright Corp. (NYSE: CW), FARO Technologies Inc. (NASDAQ: FARO) and Affymetrix Inc. (NASDAQ: AFFX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2059-100free. -- Waters Corp. Analyst Notes On April 29, 2014, Waters Corp. (Waters) reported its Q1 FY 2014 financial results (period ended March 29, 2014), with sales of $430.5 million that remained flat as compared to Q1 2013. Net income stood at $70.3 million or $0.82 per diluted share, compared to $121.1 million or $1.39 per diluted share in Q1 FY 2013 (period ended March 30, 2013). Douglas A. Berthiaume, Chairman, President and CEO of the Company, commented, "Sales in the quarter were below our expectations due primarily to a combination of slower growth in Asia and delays in the release of capital budgets, most significantly in the United States. Foreign currency translation and a higher operating tax rate negatively affected E.P.S in comparison to the 2013 first quarter's results." The full analyst notes on Waters are available to download free of charge at: http://www.analystsreview.com/2059-WAT-06May2014.pdf -- Allegion plc Analyst Notes On April 30, 2014, Allegion plc (Allegion) announced its acquisition of Fire & Security Hardware Pty Limited, a leading electromechanical locking provider in Australia. According to the Company, the transaction strengthens Allegion's presence in the Australian security market while bringing innovative electro-mechanical technologies that can be applied globally. Allegion added that the acquisition gives the Company ownership of the FSH brand and product portfolio. Dave Petratis, Chairman, President and CEO of Allegion said, "Allegion's acquisition of FSH strengthens our position in Australia and adds new electronic technologies that will integrate well with our global product lines. It's a great example of the innovative and opportunistic acquisitions we said we'd complete at our investor day in March." The full analyst notes on Allegion are available to download free of charge at: http://www.analystsreview.com/2059-ALLE-06May2014.pdf -- Curtiss-Wright Corp. Analyst Notes On April 30, 2014, Curtiss-Wright Corp. (Curtiss-Wright) reported it Q1 2014 financial results with net sales growth of 8.2% YoY to $641.4 million. Net earnings totaled $35.2 million, or $0.72 per diluted share, compared to $20.9 million, or $0.44 per diluted share, in Q1 2013. "We began the year with a strong first quarter performance, as operating income and margin expanded based on execution of the profitability initiatives we outlined at our December 2013 Investor Day," said David C. Adams, President and CEO of Curtiss-Wright Corporation. "We remain focused on increasing profitability, expanding operating margins and generating strong free cash flow in order to maximize returns for our shareholders." For full year 2014, the Company anticipates sales of $2.65 to $2.70 billion and diluted EPS of $3.35 to $3.45. The full analyst notes on Curtiss-Wright are available to download free of charge at: http://www.analystsreview.com/2059-CW-06May2014.pdf -- FARO Technologies Inc. Analyst Notes On April 29, 2014, FARO Technologies, Inc. (FARO) reported its Q1 2014 financial results with sales growth of 12.2% YoY to $73.4 million. Net income grew to $5 million, or $0.29 per share compared to $4.6 million, or $0.27 per share in Q1 2013. "The first quarter was a strong start to the new fiscal year, as our results were in-line with our internal expectations," stated Jay Freeland, FARO's President & CEO. "Customer demand in all three regions was solid, driving double-digit sales growth in the Americas and Asia and an improving European market where our orders achieved double-digit growth. While we continue to exercise prudent cost control across all departments, in 2014 we are accelerating our investments in R&D, creating new products for our early stage markets such as Architecture, Engineering and Construction and Forensics, Aerospace, Automotive, and Heavy Industrial." The full analyst notes on FARO are available to download free of charge at: http://www.analystsreview.com/2059-FARO-06May2014.pdf -- Affymetrix Inc. Analyst Notes On May 1, 2014, Affymetrix Inc. (Affymetrix) reported its Q1 2014 financial results with total revenue of $83.0 million, up 6.4% YoY. Product revenue came in at $73.7 million compared to $71.6 million in Q1 2013. The Company reported net loss of $10.5 million, or $0.14 per diluted share, as compared $15.4 million, or $0.22 per diluted share, in Q1 2013. "We have achieved year-over-year revenue growth for the third consecutive quarter. Our focus on execution is clearly paying off and I'm confident that we are on track to return the Company to sustainable growth and profitability," said Frank Witney, President and CEO. Gavin Wood, EVP and CFO said, "In the first four months of this year we prepaid $6.4 million against our Senior Debt reducing our outstanding balance to approximately $33 million as of today." The full analyst notes on Affymetrix are available to download free of charge at: http://www.analystsreview.com/2059-AFFX-06May2014.pdf -- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership. =============== EDITOR'S NOTES: =============== 1. This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com. 5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com. 6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review